Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | GILD | VRTX | ||
| Company | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 60.43 | 143.56 | 457.30 | ||
| High | 60.43 | 144.65 | 460.00 | ||
| Low | 59.45 | 142.77 | 450.67 | ||
| Latest | 60.29 | 143.93 | 456.69 | ||
| Change | -0.45 | -1.21 | -4.13 | ||
| % Change | -0.74% | -0.83% | -0.90% | ||
| Volume | 11,401,900 | 4,921,300 | 1,171,600 | ||
| 20-Day Average Volume | 13,281,535 | 7,638,000 | 1,476,815 | ||
| Previous Close | 60.74 | 145.14 | 460.82 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 60.99 | 149.85 | 475.40 | ||
| 20-Day Raw Stochastic | 28.99% | 7.99% | 11.31% | ||
| 20-Day Relative Strength | 55.96 | 51.63 | 45.72 | ||
| Weighted Alpha | +12.15 | +30.66 | -1.84 | ||
| Today's Opinion | 88% Buy | 88% Buy | 64% Buy | ||
| Previous Opinion | 88% Buy | 88% Buy | 64% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.33% since 02/27/26 | -3.37% since 02/27/26 | -8.08% since 02/27/26 | ||
| Low | 59.44 on 03/06/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 | ||
| High | 62.89 on 03/02/26 | 150.77 on 03/02/26 | 498.02 on 03/02/26 | ||
| 1-Month | |||||
| %Chg | -2.74% since 02/06/26 | -5.62% since 02/06/26 | -4.44% since 02/06/26 | ||
| Low | 59.23 on 02/19/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 | ||
| High | 62.89 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 | ||
| 3-Month | |||||
| %Chg | +15.61% since 12/05/25 | +18.73% since 12/05/25 | +0.27% since 12/05/25 | ||
| Low | 50.33 on 12/10/25 | 116.88 on 01/05/26 | 429.00 on 01/20/26 | ||
| High | 62.89 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 | ||
| 6-Month | |||||
| %Chg | +27.90% since 09/05/25 | +25.10% since 09/05/25 | +15.29% since 09/05/25 | ||
| Low | 42.52 on 10/29/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 | ||
| High | 62.89 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 122,779,024 | 178,677,728 | 116,014,792 | ||
| Shares Outstanding, K | 2,036,474 | 1,241,421 | 254,034 | ||
| Annual Sales | 48,194,000,000 | 29,443,000,000 | 12,001,300,000 | ||
| Annual Net Income | 7,054,000,000 | 8,510,000,000 | 3,953,200,000 | ||
| Last Quarter Sales | 12,502,000,000 | 7,925,000,000 | 3,190,000,000 | ||
| Last Quarter Net Income | 1,086,000,000 | 2,183,000,000 | 1,191,100,000 | ||
| 60-Month Beta | 0.26 | 0.37 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.26 on 02/05/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 | ||
| Latest Earnings Date | 04/23/26 | 04/23/26 | 05/04/26 | ||
| Most Recent Dividend | 0.630 on 01/02/26 | 0.790 on 12/15/25 | N/A | ||
| Next Ex-Dividends Date | 04/02/26 | 03/13/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 9.88 | 17.81 | 28.06 | ||